カテゴリー： MarketsandMarkets, 医療/バイオ

治療薬モニタリングの世界市場：製品（消耗品、装置）、技術（イムノアッセイ、プロテオミクス技術）

【英語タイトル】Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, Proteomic Technologies), Class of Drug (Antiepileptics, Antibiotics, Immunosuppressants), End User (Hospital Labs, Private Labs) - Global Forecast to 2020

MarketsandMarketsが出版した調査資料（MAM-MD-4185）・商品コード：MAM-MD-4185
・発行会社（調査会社）：MarketsandMarkets
・発行日：2016年3月23日
・ページ数：143
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD5,650 ⇒換算￥615,850見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥724,850見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥888,350見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
当調査レポートでは、治療薬モニタリングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別分析、技術別分析、薬剤種類別分析、需要先別分析、市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The therapeutic drug Monitoring market is projected to reach USD 2.55 Billion by 2020 from USD 1.78 Billion in 2015, growing at a CAGR of 7.4% during the forecast period (2015–2020).

Technological advances in tests used to monitor therapeutic drugs, increased knowledge of pharmacogenetics and pharmacokinetics of drugs, need for better healthcare in developing countries, and rising prevalence of psychiatric diseases and cancer are the major drivers for the market. Adjunct technologies such as biomarker identification using proteomics to accurately identify clinical outcomes and genetic testing are expected to benefit the growth of the therapeutic drug monitoring market. However, high infrastructure costs and dearth of skilled resources may restraint the market growth.

The therapeutic drug monitoring market is broadly segmented by product, technology, class of drug, end user, and region. On the basis of product, the market is segmented into consumables and equipment. The equipment market is further segmented into immunoassay analyzers, proteomic equipment, and other equipment. The consumables segment is expected to account for nearly two-thirds of the global market. The immunoassay analyzers segment is expected to be the fastest-growing segment in its equipment market. Comparatively low costs of immunoassay analyzers and their ease of use are the primary factors driving the market growth in this segment.

On the basis of technology, the therapeutic drug monitoring market is categorized into three segments namely, immunoassays, proteomic technologies and others. The immunoassays segment is expected to account for the largest share of its technology market in 2015. Factors such as relatively simple tests and requirement of minimal training to handle the immunoassay analyzers will drive the growth of this segment.

On the basis of class of drug, the therapeutic drug monitoring market is segmented into antiepileptics, antibiotics, immunosuppressants, antiarrhythmic drugs, bronchodilators, psychoactive drugs, and others classes. The antiepileptics segment is estimated to account for the largest share in 2015. By end user, the market is divided into hospital labs, commercial/private labs, and other end users. The hospital labs segment is estimated to account for the largest share in 2015.

North America is expected to account for more than half the therapeutic drug monitoring market share in 2015. It is the prime market for therapeutics drug monitoring due to the high awareness and acceptance of the benefits of therapeutic drug monitoring and growing healthcare expenditure. The market in Europe on the other hand is growing at a slower rate as the healthcare sector is recovering from the economic downturn and the healthcare facilities are trying to minimize healthcare delivery costs. Growth in the APAC therapeutic drug monitoring market is comparatively slower due to the dearth of skilled healthcare personnel for performing therapeutic drug monitoring tests with minimal errors.

Major players in the therapeutic drug monitoring market include F. Hoffmann-La Roche AG (Switzerland), Siemens Healthcare (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), and Danaher Corporation (U.S.).

【レポートの目次】

1 Introduction (Page No. – 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.2.1 Key Industry Insights
2.2.3 Assumptions for the Study

3 Executive Summary (Page No. – 25)

4 Premium Insights (Page No. – 30)
4.1 Therapeutic Drug Monitoring: Market Overview
4.2 Geographical Analysis: Market, By Classes of Drug (2015)
4.3 Geographical Snapshot of the Market, 2015
4.4 Market, By Technology
4.5 Its Equipment Market, By Type

5 Market Overview (Page No. – 34)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.4 Drivers
5.4.1 Advances in Drug Pharmacokinetics and Pharmacogenetics to Increase the Demand for Therapeutics Drug Monitoring
5.4.2 Use of TDM in Traditional Anticancer Therapies
5.5 Restraints
5.5.1 Lack of Financial Provision for Clinical Interpretation of TDM Results
5.6 Opportunities
5.6.1 Enabling Personalized Medicine Via Therapeutic Drug Monitoring While Reducing Healthcare Costs
5.7 Challenges
5.7.1 Dearth of Skilled Professionals to Perform Tests and Interpret Results

6 Therapeutic Drug Monitoring Market, By Product (Page No. – 39)
6.1 Introduction
6.2 Consumables
6.3 Equipment
6.3.1 Immunoassay Analyzers
6.3.2 Proteomics Equipment
6.3.3 Other Equipment

7 Therapeutic Drug Monitoring Market, By Technology (Page No. – 48)
7.1 Introduction
7.2 Immunoassays
7.2.1 Chemiluminescent Immunoassay (CLIA)
7.2.2 Cloned Enzyme Donor Immunoassay (CEDIA)
7.2.3 Fluorescence Polarization Immunoassay (FPIA)
7.2.4 Particle-Enhanced Turbidimetric-Inhibition Immunoassay (PETININA)
7.3 Proteomic Technologies
7.3.1 Liquid Chromatography/Mass Spectrometry (LC-MS)
7.3.2 Gas Chromatography/Mass Spectrometry (GC-MS)
7.4 Other Technologies

8 Therapeutic Drug Monitoring Market, By Class of Drug (Page No. – 60)
8.1 Introduction
8.2 Antiepileptics
8.3 Antiarrhythmic Drugs
8.4 Immunosuppressants
8.5 Antibiotics
8.6 Bronchodilators
8.7 Psychoactive Drugs
8.8 Other Drug Classes

9 Therapeutic Drug Monitoring Market, By End User (Page No. – 72)
9.1 Introduction
9.2 Hospital Labs
9.3 Commercial/Private Labs
9.4 Other End Users

10 Global Therapeutic Drug Monitoring Market, By Region (Page No. – 77)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.4 Asia-Pacific
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 105)
11.1 Overview
11.2 Competitive Situation and Trends
11.2.1 New Product Launches, Product Approvals, and Patents
11.2.2 Acquisitions
11.2.3 Marketing and Promotions
11.2.4 Agreements
11.2.5 Others

12 Company Profiles (Page No. – 111)
(Overview, Financials, Products & Services, Strategy, & Developments)*
12.1 Introduction
12.2 Roche Diagnostics
12.3 Siemens Healthcare
12.4 Thermo Fisher Scientific, Inc.
12.5 Danaher Corporation
12.6 Bio-Rad Laboratories, Inc.
12.7 Abbott Laboratories
12.8 Agilent Technologies
12.9 Biomérieux
12.10 Alere Inc.
12.11 Sekisui Medical Co. Ltd.

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 133)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports

List of Tables (80 Tables)

Table 1 Global Therapeutic Drug Monitoring Market Size, By Product, 2013–2020 (USD Million)
Table 2 Global Consumables Market Size, By Region, 2013–2020 (USD Million)
Table 3 North America: Consumables Market Size, By Country, 2013–2020 (USD Million)
Table 4 Global Equipment Market Size, By Region, 2013–2020 (USD Million)
Table 5 North America: Equipment Market Size, By Country, 2013–2020 (USD Million)
Table 6 Global Equipment Market Size, By Product, 2013–2020 (USD Million)
Table 7 Global Immunoassay Analyzers Market Size, By Region, 2013–2020 (USD Million)
Table 8 Global Proteomic Technologies Market Size, By Region, 2013–2020 (USD Million)
Table 9 Global Other Equipment Market Size, By Region, 2013–2020 (USD Million)
Table 10 Global Therapeutic Drug Monitoring Market Size, By Technology, 2013-2020 (USD Million)
Table 11 Immunoassays in Market Size, By Region, 2013-2020 (USD Million)
Table 12 Immunoassay in Market Size, By Type, 2013-2020 (USD Million)
Table 13 CLIA in Market Size, By Region, 2013-2020 (USD Million)
Table 14 CEDIA in Market Size, By Region, 2013-2020 (USD Million)
Table 15 FPIA in Market Size, By Region, 2013-2020 (USD Million)
Table 16 PETININA in Market Size, By Region, 2013-2020 (USD Million)
Table 17 Proteomic Technologies in Market Size, By Region, 2013-2020 (USD Million)
Table 18 Proteomic Technologies in Market Size, By Type, 2013-2020 (USD Million)
Table 19 LC-MS in Market Size, By Region, 2013-2020 (USD Million)
Table 20 GC-MS in Market Size, By Region, 2013-2020 (USD Million)
Table 21 Other Technologies Market Size, By Region, 2013-2020 (USD Million)
Table 22 Global Market Size, By Class of Drug, 2013–2020 (USD Million)
Table 23 Global Antiepileptics Monitoring Market Size, By Region, 2013-2020 (USD Million)
Table 24 North America: Antiepileptics Monitoring Market Size, By Country, 2013-2020 (USD Million)
Table 25 Global Antiarrhythmic Drugs Monitoring Market Size, By Region, 2013-2020 (USD Million)
Table 26 North America: Antiarrhythmic Drugs Monitoring Market Size, By Country, 2013-2020 (USD Million)
Table 27 Global Immunosuppressants Monitoring Market Size, By Region, 2013-2020 (USD Million)
Table 28 North America: Immunosuppressants Monitoring Market Size, By Country, 2013-2020 (USD Million)
Table 29 Global Antibiotics Monitoring Market Size, By Region, 2013-2020 (USD Million)
Table 30 North America: Antibiotics Monitoring Market Size, By Country, 2013-2020 (USD Million)
Table 31 Global Bronchodilators Monitoring Market Size, By Region, 2013-2020 (USD Million)
Table 32 North America: Bronchodilators Monitoring Market Size, By Country, 2013-2020 (USD Million)
Table 33 Global Psychoactive Drugs Monitoring Market Size, By Region, 2013-2020 (USD Million)
Table 34 North America: Psychoactive Drugs Monitoring Market Size, By Country, 2013-2020 (USD Million)
Table 35 Other Therapeutic Drug Classes Monitoring Market Size , By Region, 2013-2020 (USD Million)
Table 36 TDM Market Size, By End User, 2013–2020 (USD Million)
Table 37 TDM Market Size for Hospital Labs, By Region, 2013-2020 (USD Million)
Table 38 TDM Market Size for Commercial/Private Labs, By Region, 2013-2020 (USD Million)
Table 39 TDM Market Size for Other End Users, By Region, 2013-2020 (USD Million)
Table 40 Market Size, By Region, 2013–2020 (USD Million)
Table 41 North America: Market Size, By Product, 2013–2020 (USD Million)
Table 42 North America: Equipment Market Size, By Type, 2013–2020 (USD Million)
Table 43 North America: Market Size, By Technology, By Type, 2013–2020 (USD Million)
Table 44 North America: Market Size for Immunoassays, By Type, 2013–2020 (USD Million)
Table 45 North America: Market Size for Proteomics, By Type, 2013–2020 (USD Million)
Table 46 North America: Market Size, By Class of Drug, 2013–2020 (USD Million)
Table 47 North America: Market Size, By End User, 2013–2020 (USD Million)
Table 48 U.S.: Market Size, By Product, 2013—2020 (USD Million)
Table 49 U.S.: Equipment Market Size, By Type, 2013–2020 (USD Million)
Table 50 U.S.: Market Size, By Technology, 2013–2020 (USD Million)
Table 51 U.S.: Market Size for Immunoassays, By Type, 2013–2020 (USD Million)
Table 52 U.S.: Market Size for Proteomics, By Type, 2013–2020 (USD Million)
Table 53 U.S.: Market Size, By Class of Drug, 2013–2020 (USD Million)
Table 54 U.S.: Market Size, By End User, 2013–2020 (USD Million)
Table 55 Canada: Market Size, By Product, 2013–2020 (USD Million)
Table 56 Canada: Equipment Market Size, By Type, 2013–2020 (USD Million)
Table 57 Canada: Market Size, By Technology, 2013–2020 (USD Million)
Table 58 Canada: Market Size for Immunoassays, By Type, 2013–2020 (USD Million)
Table 59 Canada: Market Size for Proteomics, By Type, 2013–2020 (USD Million)
Table 60 Canada: Market Size, By Class of Drug, 2013–2020 (USD Million)
Table 61 Canada: Market Size, By End User, 2013–2020 (USD Million)
Table 62 Europe: Market Size, By Product, 2013–2020 (USD Million)
Table 63 Europe: Equipment Market Size, By Type, 2013–2020 (USD Million)
Table 64 Europe: Market Size, By Technology, 2013–2020 (USD Million)
Table 65 Europe: Market Size for Immunoassays, By Type, 2013–2020 (USD Million)
Table 66 Europe: Market Size for Proteomics, By Type, 2013–2020 (USD Million)
Table 67 Europe: Market Size, By Class of Drug, 2013–2020 (USD Million)
Table 68 Europe: Market Size, By End User, 2013–2020 (USD Million)
Table 69 APAC: Market Size, By Product, 2013–2020 (USD Million)
Table 70 APAC: Equipment Market Size, By Type, 2013–2020 (USD Million)
Table 71 APAC: Market Size, By Technology, 2013–2020 (USD Million)
Table 72 APAC: Market Size, By End User, 2013–2020 (USD Million)
Table 73 RoW: Market Size, By Product, 2013–2020 (USD Million)
Table 74 RoW: Market Size, By Technology, 2013–2020 (USD Million)
Table 75 RoW: Market Size, By End User, 2013–2020 (USD Million)
Table 76 New Product Launches, Product Approvals, and Patents, 2012–2015
Table 77 Acquisitions, 2012-2015
Table 78 Marketing and Promotions , 2012–2015
Table 79 Agreements, 2012–2015
Table 80 Other Developments, 2012–2015

List of Figures (55 Figures)

Figure 1 Research Design: Therapeutic Drug Monitoring Market
Figure 2 Market Size Estimation
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Data Triangulation Methodology
Figure 5 Market Snapshot (2015 vs 2020)
Figure 6 Consumables Account for A Major Share of the Market in 2015
Figure 7 Chemiluminiscent Assays (CLIA) to Dominate the Market During the Forecast Period
Figure 8 Antiepileptics to Witness the Highest Growth Rate in the Market for Class of Drug From 2015 to 2020
Figure 9 Hospital Laboratories to Dominate the Market in the Forecast Period
Figure 10 Geographical Snapshot of the Market, 2015
Figure 11 Rising Focus on Pharmacogenetic Testing is Driving Growth in the Therapeutic Drug Monitoring Market
Figure 12 Antiepileptics Segment to Account for the Largest Share in 2015
Figure 13 North America Will Be the Fastest-Growing Market From 2015 to 2020
Figure 14 Immunoassays Segment to Witness the Highest Growth Rate From 2015 to 2020
Figure 15 Immunoassay Analyzers to Dominate the Equipment Market in 2015
Figure 16 Market Segmentation
Figure 17 Global Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 The Consumables Segment Will Dominate the Products Market During the Forecast Period (2015–2020)
Figure 19 North America to Contribute to More Than Half of the Consumables Market in the Forecast Period
Figure 20 Immunoassay Analyzers to Witness Highest Growth in the Equipment Market From 2015 to 2020
Figure 21 Market Segmentation, By Technology
Figure 22 Immunoassays Segment is Projected to Grow at the Highest CAGR During the Forecast Period
Figure 23 CLIA is Expected to Dominate the Global Immunoassays in Market in 2015
Figure 24 North America is Expected to Account for the Largest Share of the CLIA in Therapeutic Drug Monitoring Market During the Forecast Period
Figure 25 LC-MS to Dominate the Proteomic Technologies in Therapeutic Drug Monitoring Market From 2015 to 2020
Figure 26 North America is Expected to Grow at A Higher CAGR in the LC-MS in Therapeutic Drug Monitoring Market During the Forecast Period
Figure 27 Antiepileptics to Dominate the Therapeutic Drug Monitoring Market During the Forecast Period
Figure 28 North America is Expected to Account for the Largest Share of the Antiepileptics Monitoring Market in 2015
Figure 29 U.S. to Witness the Highest Growth in the Antiarrhythmic Drugs Monitoring Market in North America
Figure 30 North America is Expected to Witness the Highest Growth in the Immunosuppressants Monitoring Market During the Forecast Period
Figure 31 North America to Account for More Than Half the Global Antibiotics Monitoring Market in 2015
Figure 32 Hospital Labs to Dominate the Market, By End User
Figure 33 North America Holds Largest Share of the Hospital Labs End-User Segment
Figure 34 North America Expected to Grow at the Fastest Rate in the Commercial/Private Labs Segment
Figure 35 North America to Lead the Market for Other End Users
Figure 36 Geographic Snapshot (2015): North America Will Be the Fastest-Growing Region By 2020
Figure 37 North America, an Attractive Destination for the Market
Figure 38 North America Therapeutic Drug Market Snapshot
Figure 39 Immunoassay Analyzers Estimated to Dominate the North America Equipment Market in 2015
Figure 40 CLIA Estimated to Be the Fastest-Growing Segment in the U.S. Therapeutic Drug Monitoring Market for Immunoassays
Figure 41 Europe Therapeutic Drug Market Snapshot
Figure 42 Antiepileptic Drugs to Dominate European Market in 2015
Figure 43 Hospital Laboratories to Account for the Largest Share of the Therapeutic Drug Monitoring Market, By End User, in APAC
Figure 44 Companies Adopted New Product Launches as Their Key Growth Strategy Over the Last Three Years (2013-2016)
Figure 45 Battle for Market Share: New Product Launches, Product Approvals, and Patents—Key Growth Strategy Adopted By Players in the Therapeutic Drug Monitoring Market
Figure 46 Geographic Revenue Mix of the Top Three Market Players
Figure 47 Company Snapshot: Roche Diagnostics
Figure 48 Company Snapshot: Siemens Healthcare
Figure 49 Company Snapshot: Thermo Fisher Scientific, Inc.
Figure 50 Company Snapshot: Danaher Corporation
Figure 51 Company Snapshot: Bio-Rad Laboratories, Inc.
Figure 52 Company Snapshot: Abbott Laboratories
Figure 53 Company Snapshot: Agilent Technologies
Figure 54 Company Snapshot: Biomérieux
Figure 55 Company Snapshot: Alere Inc.

【レポートのキーワード】

治療薬モニタリング、製品、消耗品、イムノアッセイ装置、イムノアッセイ技術、プロテオミクス技術、抗てんかん薬、抗不整脈薬、免疫抑制薬、向精神薬、気管支拡張薬、医療、監視、管理、病院

★調査レポート[治療薬モニタリングの世界市場：製品（消耗品、装置）、技術（イムノアッセイ、プロテオミクス技術）] (コード：MAM-MD-4185)販売に関する免責事項を必ずご確認ください。
★調査レポート[治療薬モニタリングの世界市場：製品（消耗品、装置）、技術（イムノアッセイ、プロテオミクス技術）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • イムノアッセイ（免疫学的検定）の世界市場予測（～2023年）：試薬・キット、分析装置、ソフトウェア
    MD4751 / MarketsandMarkets / 2018年5月14日 / MarketsandMarketsが発行した当調査レポートでは、イムノアッセイ（免疫学的検定）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品・サービス（試薬・キット、分析装置、ソフトウェア）別分析、技術別分析、プラットフォーム別分析、用途別分析、イムノアッセイ（免疫学的検定）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global immunoassays market is expected to reach USD 27.15 Billion by 2023 from USD 20.19 Billion in 2018, at a CAGR of 6.1%. The market growth is primarily driven by the increasing incidence of chronic and infectious diseases and technological innovations in immunoassays instruments. The global immunoassays market is segmented by product and service, platform, technology, specimen type, application, end user, and region. By product and service, the market is segmented into reagents and kits, analyzers, and software & services. The immunoassay reagents and kits segment accounted for the largest share of this market in 2017. The large share...
  • 神経科学研究用抗体およびアッセイの世界市場：製品別（試薬、器具）、技術別（イムノアッセイ、分子診断）、エンドユーザー別（研究機関、病院）、地域別予測
    BZW806047 / Bizwit Research & Consulting / 2018年6月4日 / 本資料は、神経科学研究用抗体およびアッセイの世界市場について調べ、神経科学研究用抗体およびアッセイの世界規模、市場動向、市場環境、製品別（試薬、器具）分析、技術別（イムノアッセイ、分子診断）分析、エンドユーザー別（研究機関、病院）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・神経科学研究用抗体およびアッセイの世界市場概要 ・神経科学研究用抗体およびアッセイの世界市場環境 ・神経科学研究用抗体およびアッセイの世界市場動向 ・神経科学研究用抗体およびアッセイの世界市場規模 ・神経科学研究用抗体およびアッセイの世界市場規模：製品別（試薬、器具） ・神経科学研究用抗体およびアッセイの世界市場規模：技術別（イムノアッセイ、分子診断） ・神経科学研究用抗体およびアッセイの世界市場規模：エンドユーザー別（研究機関、病院）...Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market to reach USD 5.1 billion by 2025. Global NEUROSCIENCE ANTIBODIES AND ASSAYS Market valued approximately USD 2.1 billion in 2016 is anticipated to grow with a healthy growth rate of more than 10.3% over the forecast period 2017-2025. The increasing automation of high-throughput screening and the availability of robust data management software tools, which enable researchers to develop systemic and process-oriented approaches toward neuroscience antibodies and assays techniques are some of the factors contributing to the growth of this segment. The objective of the study is to define market sizes of different segments &...
  • 治療薬モニタリングの世界市場予測（～2023年）
    MD-4185 / MarketsandMarkets / 2018年8月22日 / MarketsandMarketsが発行した当調査レポートでは、治療薬モニタリングの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別（消耗品、装置）分析、技術別（蛍光免疫測定、放射免疫測定法、GCMS）分析、薬剤クラス別（抗生物質、気管支拡張剤）分析、エンドユーザー別（病院内ラボ）分析、治療薬モニタリングの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global therapeutic drug monitoring (TDM) market is projected to reach USD 1.63 billion by 2023 from USD 1.23 billion in 2018, at a CAGR of 5.9% during the forecast period. Market growth is largely driven by factors rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies. In this report, the market has been categorized based on product, class of drugs, technology, end user, and region. On the basis of technology, the therapeutic drug monitoring market is segmented into immunoassay and chromatography & MS. In 2018, the immunoassay segment is expected to account for...
  • 治療薬剤モニタリングの世界市場2017-2021
    IRTNTR12643 / Technavio / 2017年4月19日 / 当調査レポートでは、治療薬剤モニタリングの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、治療薬剤モニタリングの世界市場規模及び予測、製品別分析、需要先別分析、薬剤種類別分析、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...ABSTRACTAbout Therapeutic Drug Monitoring Therapeutic drug monitoring is a branch of clinical pharmacology and clinical chemistry that specializes in the measurement of drug concentration in blood. It is mainly performed on the drugs with a narrow therapeutic window. Therapeutic drug monitoring aims at improving patient care by regulating the dose of drugs. It is based on a priori pharmacogenetic, demographic, and clinical information. It also considers a posteriori measurement of drug concentration in the blood. Technavio’s analysts forecast the global therapeutic drug monitoring market to grow at a CAGR of 7.5% during the period 2017-2021. [Covered in this report] The...
  • ウェアラブル医療機器の世界市場予測（～2022年）：診断機器、治療機器、スマートウォッチ、パッチ
    MAM-MD-4808 / MarketsandMarkets / 2018年1月23日 / MarketsandMarketsが発行した当調査レポートでは、ウェアラブル医療機器の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、診断機器種類別分析、治療機器種類別分析、用途別分析、種類別分析、ウェアラブル医療機器の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The wearable medical devices market is expected to reach USD 14.41 Billion by 2022 from USD 6.22 Billion in 2017, at a CAGR of 18.3% during the forecast period. Factors such as technological advances in medical devices, increasing penetration of smartphones and growing number of smartphone-based healthcare apps compatible with wearable devices, growing preference for wireless connectivity among healthcare providers, and increasing awareness about physical fitness are driving the growth of this market. The report segments the global wearable medical devices market into type, application, device type, distribution channel, and region. Based on type, the market is further classified into...

    • ◆H&Iグローバルリサーチのお客様（例）◆